Amid Market Uncertainty, Trump Administration Retreats from Health Plan Oversight

In mid-April, the Trump administration announced it would stop monitoring marketplace plans for compliance with several important federal protections and instead defer to states. In their latest blog post for The Commonwealth Fund, Justin Giovannelli and Kevin Lucia explain the new changes to insurance oversight, and assess the potential impact of this federal deregulation for states and consumers. Continue reading

Regulatory Activity in Two States Restricts How Plans Structure Specialty Drug Coverage

Two state insurance regulators, Florida and Montana, have taken recent regulatory action to address concerns raised by advocacy groups about the way specialty drugs are covered in pharmacy benefit plans offered in their states. Sally McCarty provides details of those actions and related updates on the oversight of discriminatory benefit designs. Continue reading

Some States Consider Nondiscrimination Requirements

In implementing the Affordable Care Act, state regulators may increasingly look for ways to ensure that health insurance does not discriminate against certain groups of individuals, such as people living with HIV, older Americans, and even women. In this spirit, Katie Keith describes how Colorado and the District of Columbia each took recent steps to prohibit insurers from discriminating against enrollees based on gender identity and sexual orientation. Continue reading